TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Health-Related Quality of Life (HRQOL) Physical Component Score (PCS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Active minutes per day
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Side effects of cyclosporine
Endpoint domain: Adverse events/effects
Primary endpoint: Force sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of otological and systemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline subjective memory complaints
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Level of IL33
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Biochemically verified 7 day smoking abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of intervention implementation in PE lessons
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Success of intervention implementation in school systems
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Success of intervention implementation for pupils
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Treatment Limiting Toxicity (TLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Combined assessment of function and survival (CAFS)
Endpoint domain: Mortality/survival
Primary endpoint: Percent of participants successfully swallowing the Mock-RP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All adverse events categorized by type and frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse reactions to ESKETAMINE
Endpoint domain: Adverse events/effects
Primary endpoint: Knee ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Primary patency of the prothesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With Technical Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum asprosin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of internet gaming addiction in adolescents
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Weaning Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Days of Mechanical Ventilator
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Any adverse event after treatment
Endpoint domain: Adverse events/effects
Primary endpoint: long term function of vascularized bladder allotransplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of days return to work after COVID-19 infection
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: finger muscle power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sensory block success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 12-month disease-free survival (DFS)
Endpoint domain: Mortality/survival
Primary endpoint: Upper-limb kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Student Functioning at Home
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Student Functioning at School
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Fitness (time to complete fitness test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep quality and quantity (Pittsburgh Sleep Quality Index)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Geometric Mean Titers (GMT) of SARS-CoV-2 Omicron XBB.1.5- and Omicron BA.4/BA.5-neutralizing antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: full time sick-leave
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of patients who decide to enroll in an orthopedic clinical trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of patients who remain in orthopedic clinical trial to trial completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Brain neuroplasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Early Surgical Site Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Nelson Foot Reaction Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait and Balance Scale (Untimed Tasks)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait and Balance Scale (Timed Tasks - Cadence)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse device events (ADEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of clinically significant abnormalities on ECG, vital signs, physical examination and laboratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events (AEs) related to WBHT treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Postpartum Family Planning Attitude Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nature, severity, and number of incidences of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Nature and number of incidences of dose limiting toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute change in fasting blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Developing KDIGO stage 2 AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: High-Density Lipoprotein (HDL-c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting Blood Triglycerides Concentration (TG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Extent of Sensory Blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with injection site reactions (ISRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with abnormal safety blood results
Endpoint domain: Adverse events/effects
Primary endpoint: enteric pathogen prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 14-day enteric pathogen incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: enteric pathogen diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Total morphine dose equivalents administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The incidence of treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: The change from baseline in pulmonary function tests (PFTs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: The change from baseline in 12-lead electrocardiogram (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of dihydroartemisinin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour ABPM Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Activities-Specific Balance Confidence scale (ABC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PEQ-Well Being (PEQ-WB)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient Global Assessment of Activities Difficulty Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: FEV1 and MVV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from Baseline in Corpus Callosum Myelin Water Fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline in Corpus Callosum T1 Relaxation Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline in Corpus Callosum UTE Fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Aerobic Capacity and Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance of lung protective ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of Post Intensive Care Syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Anti inflammatory Effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect on disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal Glycemic Health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fetal Heart Tones
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal Complete Blood Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Recruitment/enrolment/attendance/dropout metrics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Composite program feedback questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Focus groups feedback
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to diet protocols
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pathological complete regression (pCR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of emergency department visits or hospital admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Planned mandibular advancement (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal muscle hypertrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Esophageal Temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viability
Endpoint domain: Mortality/survival
Primary endpoint: Safety event
Endpoint domain: Adverse events/effects
Primary endpoint: General Anxiety Disorder - 7 (GAD-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fast blood sugar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum glutamic oxaloacetic transaminase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of 24-hour urine protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: adenoma incremental detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Separation duration between mother and newborn
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Eye Fixations Numbers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eye Fixation duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Symptom severity (GAD7-PHQ9)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fascicle length of hamstring muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross motor function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximum Tolerated Dose (MTD) of mitoxantrone hydrochloride liposome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (Cmax) of TP-3654 in a capsule formulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) of TP-3654 in a capsule formulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of Peak Plasma Concentration (Cmax) of TP-3654 tablet versus capsule
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing of surgical wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of SPA in IBD patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Epidiferphane's components
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of taxanes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of CTCAE v5.0 grade 2 or higher neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of CTCAE v5.0 grade 1 or higher anemia
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of at home monitoring
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: biomarkers of the disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Plaque Burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Change During Dressing Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety Change During Dressing Changes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Nausea Change During Dressing Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UMSARS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PSP-CDS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difference in expressed genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure of stainless steel crowns
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Adverse Event(s)
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of osteoporosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and joint outcomes
Primary endpoint: Fatigue Intensity Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Visual Sleep Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Pediatric Quality of Life Inventory (PedsQL) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Revised Cystic Fibrosis Questionnaire Child Form
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional Disability Inventory Child
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Post traumatic growth of mentors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Life satisfaction of mentors
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Life satisfaction of mentees
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Overall graft survival at Year 3
Endpoint domain: Mortality/survival
Primary endpoint: Clinical malaria incidence
Endpoint domain: Mortality/survival
Primary endpoint: Rates of successful cervical ripening at the end of 12 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of cervical ripening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Scale for Assessment and Rating for Ataxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cerebellar Cognitive Affective Syndrome Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient Reported Outcome Measure for Ataxia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Baseline Depression, Anxiety and Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Baseline Caregiver Burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Change in Baseline Caregiver Participation in Meaningful and Fulfilling Activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of patients with high viral load of SARS-CoV-2 in feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: the quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area under plasma concentration versus time curve (AUC) from time zero to last quantifiable concentration [AUC(0-t)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under plasma concentration versus time curve (AUC) from time zero to infinity [AUC(0-∞)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anticipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Oxygenated hemoglobin (HbO) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diet Induced Thermogenesis (DIT) AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Development of a rheumatic disease
Endpoint domain: Mortality/survival
Primary endpoint: BICR-PFS
Endpoint domain: Mortality/survival
Primary endpoint: Anesthesia quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and nature of TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: anti-tumour response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Efficacy of ropeginterferon alfa-2b-njft
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of MRT-6160
Endpoint domain: Adverse events/effects
Primary endpoint: Modification of amplitude measured with flash and pattern electroretinogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Modification of implicite time measured with flash and pattern electroretinogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: sensitivity and specificity of the clinical standard
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity and specificity of 'ATI recommendation' by the algorithm vs. 'VL/DL'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity and specificity of 'DL recommendation' by the algorithm vs. 'VL/ATI'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity and specificity of 'VL recommendation' by the algorithm vs. 'DL/ATI'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who complete the cognitive interview
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Average score on the Neuropsychiatric Inventory (NPI) agitation domain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area under the concentration-time curve from time zero to last time of quantifiable concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of the breast density classification algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with SARS-CoV-2 infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in quality of life (QoL) using SGRQ
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in quality of life (QoL) using SF-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Gait symmetry index (SI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multidimensional Anxiety Scale for Children (MASC2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Screen for Child Anxiety Related Disorders (SCARED)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional connectivity in brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in depressive symptoms-related sick leave days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: number of linear stapler cartridges
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Vaginal microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum acetoacetate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in beta hydroxybutyrate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in acetone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of clinical or subclinical cardiac injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Catheter Related Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Time to post-repair fistula breakdown
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes